Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Collaboration symbols : Snynf save search
IGM Biosciences Announces Refocusing of Sanofi Collaboration
Published: 2024-04-17 (Crawled : 13:00) - globenewswire.com
SNYNF | News | $92.7 600K
|
Health Technology
|
| O: 0.12%
H: 0.51%
C: 0.51%
SNY | News | $46.34 2.09% 620K
|
Health Technology
|
| O: 1.05%
H: 0.0%
C: 0.0%
IGMS | $7.24 -2.29% 47K
|
Health Technology
|
| O: 1.85%
H: 0.0%
C: -13.23%
collaboration sanofi
Nurix Therapeutics Announces Extension of Strategic Collaboration with Sanofi to Develop Novel Targeted Protein Degraders of STAT6
Published: 2024-04-09 (Crawled : 11:00) - globenewswire.com
SNYNF | News | $92.7 600K
|
Health Technology
|
| O: 0.28%
H: 0.0%
C: 0.0%
SNY | News | $46.34 2.09% 620K
|
Health Technology
|
| O: -0.38%
H: 0.95%
C: 0.83%
NRIX 2 d | $14.215 -1.56% 110K
|
Health Technology
|
| O: 1.26%
H: 0.0%
C: 0.0%
protein collaboration extension therapeutics sanofi
Medidata and Sanofi Vaccines Extend Collaboration to Improve Patient Centricity and Trial Efficiency
Published: 2024-02-06 (Crawled : 14:00) - biospace.com/
SNY | News | $46.34 2.09% 620K
|
Health Technology
|
| O: -1.25%
H: 0.0%
C: 0.0%
collaboration trial sanofi
Synthekine Announces Strategic Collaboration with Sanofi to Develop Selective IL-10 Agonists for Treatment of Inflammatory Diseases
Published: 2024-01-29 (Crawled : 15:00) - biospace.com/
SNY | News | $46.34 2.09% 620K
|
Health Technology
|
| O: 0.12%
H: 0.0%
C: 0.0%
il-10 treatment collaboration sanofi
Innovent and Xuanzhu Enter into Clinical Trial Collaboration Investigating Combination Therapy of Sintilimab (PD-1 inhibitor) and A Novel ADC Candidate for Advanced Solid Tumors in China
Published: 2023-12-28 (Crawled : 00:00) - prnewswire.com
SNYNF | News | $92.7 600K
|
Health Technology
|
| O: 0.28%
H: 0.0%
C: -1.32%
LLY | $728.765 -2.3% 1.5M
|
Health Technology
|
| O: 0.08%
H: 0.81%
C: -0.19%
SNY | News | $46.34 2.09% 620K
|
Health Technology
|
| O: 0.52%
H: 0.72%
C: -0.34%
INCY | $52.45 -0.7% 530K
|
Health Technology
|
| O: 0.35%
H: 1.07%
C: -0.27%
candidate tumors collaboration trial advanced china therapy
Innovent and SanegeneBio Enter Strategic Collaboration to Develop siRNA Drug for the Treatment of Hypertension
Published: 2023-12-27 (Crawled : 00:00) - prnewswire.com
SNYNF | News | $92.7 600K
|
Health Technology
|
| O: 0.36%
H: 0.03%
C: 0.03%
SNY | News | $46.34 2.09% 620K
|
Health Technology
|
| O: 1.2%
H: 0.0%
C: 0.0%
INCY | $52.45 -0.7% 530K
|
Health Technology
|
| O: -0.18%
H: 0.56%
C: 0.38%
drug sirna treatment collaboration hypertension
MeiraGTx Announces Asset Purchase Agreement Involving its AAV-RPGR Collaboration for up to $415 million
Published: 2023-12-21 (Crawled : 12:00) - globenewswire.com
SNYNF | News | $92.7 600K
|
Health Technology
|
| O: -0.1%
H: 0.0%
C: 0.0%
JNJ | News | $146.39 0.45% 1.8M
|
Health Technology
|
| O: -1.87%
H: 0.0%
C: 0.0%
SNY | News | $46.34 2.09% 620K
|
Health Technology
|
| O: -0.08%
H: 0.0%
C: 0.0%
MGTX | News | $5.04 0.6% 45K
|
Health Technology
|
| O: 18.53%
H: 13.23%
C: 11.86%
collaboration agreement
Owkin enters collaboration agreement with MSD to develop AI-powered diagnostics for cancer
Published: 2023-12-19 (Crawled : 11:00) - biospace.com/
SNY | News | $46.34 2.09% 620K
|
Health Technology
|
| O: 0.45%
H: 0.0%
C: 0.0%
cancer collaboration diagnostics agreement
Maze Therapeutics Announces FTC Action Seeking to Block Collaboration and License Agreement with Sanofi Regarding MZE001, a Potential Oral Substrate Reduction Therapy for Pompe Disease
Published: 2023-12-11 (Crawled : 00:00) - biospace.com/
SNYNF | News | $92.7 600K
|
Health Technology
|
| O: 0.5%
H: 1.67%
C: 0.1%
SNY | News | $46.34 2.09% 620K
|
Health Technology
|
| O: 2.15%
H: 0.0%
C: 0.0%
mze001 disease license collaboration therapeutics potential agreement therapy sanofi
Innovent Biologics and Synaffix Expand ADC Collaboration Following Positive Preliminary Clinical Signal from Ongoing Phase 1 Study
Published: 2023-12-07 (Crawled : 01:00) - prnewswire.com
SNYNF | News | $92.7 600K
|
Health Technology
|
| O: -1.66%
H: 0.0%
C: 0.0%
SNY | News | $46.34 2.09% 620K
|
Health Technology
|
| O: -1.19%
H: 0.0%
C: 0.0%
positive ongoing collaboration study
AQEMIA Announces a Major Multi-year Collaboration of $140 Million With Sanofi
Published: 2023-12-05 (Crawled : 10:00) - biospace.com/
SNYNF | News | $92.7 600K
|
Health Technology
|
| O: 0.27%
H: 0.12%
C: 0.12%
SNY | News | $46.34 2.09% 620K
|
Health Technology
|
| O: -0.5%
H: 0.0%
C: 0.0%
multi-year collaboration sanofi
Teva Completes Closing of Exclusive Collaboration Deal to Deliver Inflammatory Bowel Disease Treatment
Published: 2023-11-30 (Crawled : 15:00) - biospace.com/
SNYNF | News | $92.7 600K
|
Health Technology
|
| O: -0.35%
H: 0.0%
C: 0.0%
TEVA | $12.975 1.53% 3.3M
|
Health Technology
|
| O: -0.52%
H: 3.73%
C: 1.87%
SNY | News | $46.34 2.09% 620K
|
Health Technology
|
| O: -1.09%
H: 0.0%
C: 0.0%
disease treatment collaboration teva deal
Simcere and Connect Enter into an exclusive license and collaboration agreement for the innovative autoimmune drug Rademikibart
Published: 2023-11-23 (Crawled : 08:00) - prnewswire.com
SNY | News | $46.34 2.09% 620K
|
Health Technology
| Email alert
Add to watchlist
SNYNF | News | $92.7 600K
|
Health Technology
| Email alert
Add to watchlist
drug license collaboration agreement
BioMap Establishes a Strategic Collaboration with Sanofi to Co-Develop AI Modules to Accelerate Drug Discovery for Biotherapeutics
Published: 2023-10-10 (Crawled : 11:00) - biospace.com/
SNY | News | $46.34 2.09% 620K
|
Health Technology
|
| O: 0.51%
H: 0.0%
C: 0.0%
drug collaboration sanofi
bioSeedin Biopharma Developer Innovation Conference Held to Accelerate Global Pharmaceutical Innovation and Collaboration
Published: 2023-10-09 (Crawled : 12:00) - prnewswire.com
SNY | News | $46.34 2.09% 620K
|
Health Technology
|
| O: 0.19%
H: 0.0%
C: 0.0%
conference innovation biopharma global collaboration
Sanofi and Teva Announce Exclusive Collaboration to Deliver Inflammatory Bowel Disease Treatment
Published: 2023-10-04 (Crawled : 08:00) - biospace.com/
TEVA | $12.975 1.53% 3.3M
|
Health Technology
|
| O: 1.46%
H: 0.21%
C: -5.65%
SNY | News | $46.34 2.09% 620K
|
Health Technology
|
| O: 1.07%
H: 0.0%
C: 0.0%
disease treatment collaboration teva sanofi
Press Release: Sanofi and Teva announce exclusive collaboration to deliver inflammatory bowel disease treatment
Published: 2023-10-04 (Crawled : 05:00) - globenewswire.com
SNY | News | $46.34 2.09% 620K
|
Health Technology
|
| O: 1.07%
H: 0.0%
C: 0.0%
disease treatment collaboration teva sanofi
Regeneron and Intellia Announce Expanded Research Collaboration to Develop CRISPR-Based Therapies for the Treatment of Neurological and Muscular Diseases
Published: 2023-10-03 (Crawled : 11:00) - globenewswire.com
SNY | News | $46.34 2.09% 620K
|
Health Technology
|
| O: -1.41%
H: 0.0%
C: 0.0%
REGN | $894.71 0.08% 180K
|
Health Technology
|
| O: -0.74%
H: 0.21%
C: -0.45%
NTLA | $21.12 -0.94% 310K
|
Health Technology
|
| O: -0.1%
H: 1.97%
C: 1.02%
treatment research collaboration neurological
Panbela Announces Issuance of New Patent in Chile for Claims of a Novel Process for the Production of FlynpoviPatent developed in collaboration with Sanofi
Published: 2023-09-05 (Crawled : 20:00) - biospace.com/
PBLA | $0.4895 66K
|
Professional, Scientific, and T...
|
| O: 1.38%
H: 4.76%
C: -0.68%
SNY | News | $46.34 2.09% 620K
|
Health Technology
|
| O: -0.93%
H: 0.0%
C: 0.0%
patent collaboration sanofi
Recludix Pharma Enters into a Strategic Collaboration with Sanofi to Advance Novel Oral STAT6 Inhibitor in Multiple Immunological and Inflammatory Indications
Published: 2023-07-20 (Crawled : 14:00) - biospace.com/
SNY | News | $46.34 2.09% 620K
|
Health Technology
|
| O: 1.2%
H: 0.7%
C: 0.27%
pharma collaboration sanofi
Gainers vs Losers
| 75% | 25% |
Top 10 Gainers
AGBA | News | $1.22 205.0% 86M
|
Finance
EGOX | $0.054 50.0% 290M
|
CHRO | $1.66 35.51% 70K
|
n/a
INDO | $5.43 33.09% 10M
|
Energy Minerals
NVFY | $2.71 28.44% 31M
|
Consumer Durables
ZCMD | $1.86 28.28% 29M
|
Commercial Services
RWOD | $10.08 26.05% 5.6M
|
n/a
HUSA 4 | $2.07 23.95% 2.1M
|
Energy Minerals
TPET | $0.4001 22.02% 35M
|
n/a
SRFM 4 | $0.6 21.29% 850K
|
n/a
Your saved searches
Save your searches and get alerts when important news are released.